Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3677112012 | Bisoprolol 5 mg and hydrochlorothiazide 6.25 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3677114013 | Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing bisoprolol fumarate | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Bisoprolol fumarate (substance) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Bisoprolol fumarate + hydrochlorothiazide | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing bisoprolol and hydrochlorothiazide (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Bisoprolol (substance) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Bisoprolol-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Bisoprolol (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Bisoprolol (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 5 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 6.25 | false | Inferred relationship | Some | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing bisoprolol and hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has precise active ingredient | Bisoprolol (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Bisoprolol and hydrochlorothiazide only product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Plays role | Diuretic therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)